It's like the B cell therapies. You know, originally all the stuff was based on T cells because T cells were the one attacking. But then they came and understood, wait, … The focus is now shifting because of things like Ocrevus and Rituxan. … is expanding at an exponential rate. And you can see it starting the signs of cracking through on all of these different issues. (24:44–24:59)
CLAIM
Asserts that research focus is shifting to primary progressive MS due to treatments like Ocrevus and Rituxan.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
